BRIEF published on 12/13/2024 at 08:10, 1 year 7 months ago Nyxoah lance la thérapie Genio® en Angleterre Apnée Obstructive Du Sommeil Nyxoah SA Lancement Sur Le Marché Thérapie Genio® Service National De Santé D'Angleterre
BRIEF published on 12/13/2024 at 08:10, 1 year 7 months ago Nyxoah Launches Genio® Therapy in England NHS England Obstructive Sleep Apnea Nyxoah SA Market Launch Genio® Therapy
PRESS RELEASE published on 12/13/2024 at 08:05, 1 year 7 months ago Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England Nyxoah announces commercial launch of Genio Innovative Therapy in England with successful implants at UCLH. Genio system covered under NHS SSDP for OSA patients Nyxoah Genio Innovative Therapy England OSA
BRIEF published on 11/06/2024 at 22:10, 1 year 9 months ago Nyxoah publie ses résultats financiers du troisième trimestre 2024 Résultats Financiers Approbation De La FDA Situation De Trésorerie Apnée Obstructive Du Sommeil Commercialisation Aux États-Unis
BRIEF published on 11/06/2024 at 22:10, 1 year 9 months ago Nyxoah Reports Third Quarter 2024 Financial Results Financial Results Cash Position FDA Approval Obstructive Sleep Apnea U.S. Commercialization
PRESS RELEASE published on 11/06/2024 at 22:05, 1 year 9 months ago Nyxoah Reports Third Quarter Financial and Operating Results Nyxoah SA reports third quarter financial and operating results, with FDA approval on track for Q1 2025 and strengthening of U.S. commercial team. Company fully funded until mid-2026 Financial Results FDA Approval Sleep Apnea Nyxoah U.S. Commercial Team
BRIEF published on 10/08/2024 at 14:05, 1 year 10 months ago Nyxoah Secures $27 Million in At-the-Market Offering Financing U.S. Market Nyxoah Neuromodulation Healthcare Investor
BRIEF published on 10/08/2024 at 14:05, 1 year 10 months ago Nyxoah obtient 27 millions de dollars lors d'une offre sur le marché Financement Marché Américain Nyxoah Neuromodulation Investisseur Dans Le Secteur De La Santé
PRESS RELEASE published on 10/08/2024 at 14:00, 1 year 10 months ago Nyxoah Raises $27 Million through its At-the-Market Offering Nyxoah raises $27 million through its At-the-Market Offering, strengthening balance sheet and U.S. focus. New investment from U.S. healthcare investor Financing At-the-market Offering Nyxoah Obstructive Sleep Apnea Healthcare Investor
BRIEF published on 09/27/2024 at 22:35, 1 year 10 months ago Nyxoah présente les données prometteuses de l'étude DREAM à l'ISSS 2024 Approbation De La FDA Apnée Obstructive Du Sommeil Données Cliniques Étude DREAM Stimulation Génio
Published on 08/10/2026 at 15:30, 2 hours 28 minutes ago Silver Spruce Resources, Inc. Announces New Chief Financial Officer
Published on 08/10/2026 at 15:25, 2 hours 33 minutes ago Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland
Published on 08/10/2026 at 14:30, 3 hours 28 minutes ago NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
Published on 08/10/2026 at 13:30, 4 hours 28 minutes ago Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
Published on 08/10/2026 at 13:00, 4 hours 58 minutes ago Alaska Energy Metals Announces Drilling Program for the Mcbride Prospect, Angliers-Belleterre Project, Quebec, Canada
Published on 08/10/2026 at 17:38, 20 minutes ago PATRIZIA delivers strong earnings growth with EUR 42.7m EBITDA (+46.6% y-o-y) in H1 2026
Published on 08/10/2026 at 17:11, 47 minutes ago CORRECTION FROM SOURCE: North Peak Commences 2026 Drilling Campaign at Prospect Mountain, Eureka, Nevada
Published on 08/10/2026 at 16:12, 1 hour 46 minutes ago dK Calls on PANDION AG Bondholders to Join Forces
Published on 08/10/2026 at 15:56, 2 hours 2 minutes ago Viromed Medical AG signs distribution partnerships for ViroCAP® in six additional markets
Published on 08/10/2026 at 15:46, 2 hours 12 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 08/10/2026 at 11:53, 6 hours 4 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:53, 6 hours 4 minutes ago GUILLEMOT CORPORATION |Informations relatives au nombre total de droits de vote et d’actions 31/07/2026
Published on 08/10/2026 at 11:36, 6 hours 22 minutes ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
